CIK 0000887359
- Large accelerated filer
Vericel Corp
Sign in to watch- Ticker
- VCEL
- Exchange
- Nasdaq
- Industry
- Biological Products, (No Diagnostic Substances)
- FY end
- Dec 31
- Incorporated
- MI
- Entity type
- Operating
- EIN
- 943096597
- Phone
- +1 617-588-5555
- Business address
- 25 BLUE SKY DRIVE, BURLINGTON, MA, 01803
- Former names
- AASTROM BIOSCIENCES INC
- Open-market buys, last 90 days
- $0
- in 0 filings
- Open-market sales, last 90 days
- $5,896,581
- in 8 filings, $5.8M under 10b5-1 plans
Net −$5,896,581. Shares bought or sold at a price by officers, directors and 10% owners (Form 4 codes P and S). Grants, option exercises and tax withholding aren't counted.
Who's trading
90 days
- Mara Joseph Anthony Jr −$4.1M Chief Financial Officer sold 82% of stake
- Flynn Sean C. −$779K Chief Legal Officer sold 88% of stake
- MCLAUGHLIN KEVIN F −$413K Director sold 28% of stake
- ZERBE ROBERT L MD −$386K Director sold 19% of stake
- SIEGAL JONATHAN −$188K Principal Accounting Officer sold 73% of stake
| Date | Insider | Transaction | Shares | Price | Value | Owned after |
|---|---|---|---|---|---|---|
| 2023-07-14 | ZERBE ROBERT L MD Director | Sale 10b5-1 | −1,000 | $38.84 | $39K | 33,395 |
| 2023-06-22 | ZERBE ROBERT L MD Director | Sale 10b5-1 | −3,000 | $36.00 | $108K | 34,395 |
| 2023-02-02 | SIEGAL JONATHAN Principal Accounting Officer | Sale | −330 | $31.00 | $10K | 675 |
| 2023-01-10 | Colangelo Dominick President and CEO | Sale | −39,938 | $27.13 | $1.1M | 157,066 |
| 2022-10-14 | SIEGAL JONATHAN Principal Accounting Officer | Sale | −331 | $25.47 | $8K | 875 |
| 2022-04-29 | GILMAN STEVEN C Director | Sale | −900 | $30.94 | $28K | 5,200 |
| 2022-03-01 | Hopper Jonathan Mark Chief Medical Officer | Sale | −10,000 | $41.41 | $414K | 45,914 |
| 2022-03-01 | Hopper Jonathan Mark Chief Medical Officer | Sale | −6,738 | $41.46 | $279K | 49,176 |
| 2021-12-22 | Hopper Jonathan Mark Chief Medical Officer | Sale | −9,000 | $40.14 | $361K | 39,428 |
| 2021-12-22 | Hopper Jonathan Mark Chief Medical Officer | Sale | −5,881 | $40.08 | $236K | 43,547 |
| 2021-12-20 | Hopper Jonathan Mark Chief Medical Officer | Sale | −1,000 | $40.00 | $40K | 39,428 |
| 2021-11-29 | GILMAN STEVEN C Director | Sale | −5,000 | $39.17 | $196K | 3,500 |
| 2021-10-27 | GILMAN STEVEN C Director | Sale | −5,000 | $50.57 | $253K | 3,500 |
| 2021-10-26 | Halpin Michael Chief Operating Officer | Sale | −10,000 | $50.57 | $506K | 5,696 |
| 2021-09-30 | GILMAN STEVEN C Director | Sale | −5,000 | $48.85 | $244K | 3,500 |
| 2021-08-27 | Flynn Sean C. VP, General Counsel | Sale | −7,200 | $55.11 | $397K | 2,419 |
| 2021-08-16 | Halpin Michael Chief Operating Officer | Sale | −15,000 | $48.03 | $720K | 5,623 |
| 2021-07-21 | Flynn Sean C. VP, General Counsel | Sale | −2,800 | $55.01 | $154K | 2,419 |
| 2021-07-15 | Flynn Sean C. VP, General Counsel | Sale | −10,000 | $51.18 | $512K | 2,419 |
| 2021-07-12 | Halpin Michael Chief Operating Officer | Sale | −20,000 | $53.54 | $1.1M | 5,623 |
Page 8 of 14 · 279 trades